Results 51 to 60 of about 29,875 (183)

Differential expression of type III effector BteA protein due to IS481 insertion in Bordetella pertussis. [PDF]

PLoS ONE, 2011
BACKGROUND: Bordetella pertussis is the primary etiologic agent of the disease pertussis. Universal immunization programs have contributed to a significant reduction in morbidity and mortality of pertussis; however, incidence of the disease, especially ...
Hyun-Ja Han, Asaomi Kuwae, Akio Abe, Yoshichika Arakawa, Kazunari Kamachi   +4 more
doaj   +1 more source

Bordetella pertussis Polymorphism and Pertussis Vaccines [PDF]

Clinical and Vaccine Immunology, 2008
The topic of the article by Bottero et al. (1) is an important one, a bacterial vaccine for a preventable disease, pertussis. Many articles have been published on the subject in the last 10 years (for a review, see reference 6). In their study, Bottero et al.
openaire   +2 more sources

The Effect of Maternal Pertussis Vaccination on Neonatal Health Outcomes in the Dutch Pregnancy Drug Register

Birth Defects Research, Volume 118, Issue 4, April 2026.
ABSTRACT Background The currently high pertussis‐related morbidity and mortality among infants has led to increased international attention for pertussis vaccination during pregnancy. We studied the safety of maternal pertussis vaccination in the Netherlands with respect to neonatal health. Methods Data from the cohort the Dutch Pregnancy Drug Register
Petra J. Woestenberg, Veronique Y. F. Maas, Maud de Feijter, Leontine van Balveren, Maartje Conijn, Sanne Boetzkes, Anneke J. L. M. Passier, Agnes C. Kant   +7 more
wiley   +1 more source

Impact of Routine Respiratory Pathogen Panel Test on Outcome of Pediatric Oncology Patients With Febrile Neutropenia

Cancer Reports, Volume 9, Issue 4, April 2026.
ABSTRACT Background Infection is a significant cause of morbidity and mortality in pediatric oncology patients, especially during neutropenia. While bacterial infections are traditionally considered the primary cause of febrile neutropenia, the growing use of respiratory pathogen panels (RPPs) for viral detection in children has not been extensively ...
Farrah Gaston, Alexander Tran, Collins Odhiambo, Mustafa Bakir   +3 more
wiley   +1 more source

Pertactin-Negative and Filamentous Hemagglutinin-Negative Bordetella pertussis, Australia, 2013–2017

Emerging Infectious Diseases, 2019
During the 2008–2012 pertussis epidemic in Australia, pertactin (Prn)–negative Bordetella pertussis emerged. We analyzed 78 isolates from the 2013–2017 epidemic and documented continued expansion of Prn-negative ptxP3 B. pertussis strains.
Zheng Xu, Sophie Octavia, Laurence Don Wai Luu, Michael Payne, Verlaine Timms, Chin Yen Tay, Anthony D. Keil, Vitali Sintchenko, Nicole Guiso, Ruiting Lan   +9 more
doaj   +1 more source

Diversity of Rhinovirus and Enterovirus Infections Among Pediatric Patients Hospitalized in Wisconsin, 2022–2023

Journal of Medical Virology, Volume 98, Issue 4, April 2026.
ABSTRACT Severe rhinovirus (RV)/enterovirus (EV) respiratory infections in pediatric patients increased in the US during 2022–2023. This study aimed to characterize RV/EV genetic diversity among hospitalized children in Wisconsin and describe demographic and clinical factors of patients by RV/EV type.
Hannah L. Litwak, Carlos M. Perez, Allen Bateman, Kyley Anhalt, Xiaoyan Lu, Shannon Rogers, Brian Emery, Terry Fei Fan Ng, Caelin Cubenas, Cria O. Gregory, Clinton Paden, Thomas Haupt, Hannah L. Kirking, Hannah E. Segaloff   +13 more
wiley   +1 more source

Impact of Nirsevimab on Respiratory Syncytial Virus PCR Test Positivity in Young Infants: A Community‐Level Observational Study in Queensland, Australia

Journal of Paediatrics and Child Health, Volume 62, Issue 4, Page 614-620, April 2026.
ABSTRACT Aim In April 2024 nirsevimab, a long‐acting respiratory syncytial virus (RSV)‐specific monoclonal antibody, was made available free of charge to all newborn infants in Queensland. We aimed to explore the community‐level impact of a nirsevimab‐based prevention program on RSV detection percentages among infants aged ≤ 3 months in Queensland ...
Asmaa El‐Heneidy, Keith Grimwood, Jennifer M. Robson, Chanpaseuth Vicki Vilaylath, Sarah G. Cherian, Stephen B. Lambert, Robert S. Ware   +6 more
wiley   +1 more source

Maternal pertussis is hazardous for a newborn: a case report

The Turkish Journal of Pediatrics, 2010
Pertussis, or whooping cough, a highly contagious disease caused by Bordetella pertussis, is making a comeback globally and nationally in spite of reasonable vaccination coverage.
Didem Armangil, Gülsevin Tekinalp, Murat Yurdakök, Ebru Yalçin   +3 more
doaj  

Pertussis em Portugal – A importância de uma nova estratégia vacinal

Revista Portuguesa de Pneumologia, 2010
Resumo: A introdução da vacina antipertussis nos programas de vacinação originou uma diminuição drástica da incidência de tosse convulsa no mundo.
Susana Gama de Sousa, Henrique Barros
doaj   +1 more source

Hypercapnia as a Key Mechanism in the Development of Pulmonary Hypertension in Malignant Pertussis: A Case Report

Respirology Case Reports, Volume 14, Issue 3, March 2026.
Despite intensive care advances, malignant pertussis (MP) remains highly lethal. Our case suggests that hypercapnia‐induced pulmonary vasoconstriction may play a reversible role in MP pathophysiology. Thus, targeting hypercapnia control could represent a promising therapeutic approach in managing this severe complication.
Juan Ignacio Muñoz‐Bonet, Francisco José Sebastián‐Cuevas, Eva María Flor‐Macián, María del Carmen Ortega‐Sánchez, Andrés Rodríguez‐Sacristán, Juan Brines   +5 more
wiley   +1 more source